What is Enlitic?
Enlitic specializes in providing high-quality software-as-a-medical-device solutions tailored for radiologists. The company is committed to meeting and exceeding applicable regulatory, statutory, and quality requirements, with a core mission to improve patient healthcare outcomes. By leveraging advanced software, Enlitic aims to enhance the diagnostic capabilities and efficiency of radiological practices, positioning itself as a key player in the digital health transformation within medical imaging.
How much funding has Enlitic raised?
Enlitic has raised a total of $36.4M across 4 funding rounds:
Angel/Seed
$2M
Series A
$3M
Series B
$25M
Other Financing Round
$6.4M
Angel/Seed (2014): $2M with participation from Amplify.La Capital II and Data Collective
Series A (2015): $3M, investors not publicly disclosed
Series B (2019): $25M supported by Thorney Investment Group, Amplify Partners, Capitol Health, Regal Funds Management, The Jagen Group, and Marubeni Corporation
Other Financing Round (2025): $6.4M, investors not publicly disclosed
Key Investors in Enlitic
Thorney Investment Group
Thorney Investment Group is an ASX-listed investment company focused on generating absolute returns through the careful selection of investments, often acting as a constructive catalyst for value creation in identified companies.
Amplify Partners
Amplify Partners invests in early-stage companies in machine intelligence and computer science, leveraging deep domain expertise and industry relationships to support technical founding teams.
Regal Funds Management
Regal Funds Management is an Australian alternative investment manager specializing in long/short strategies, known for its multi-award-winning investment approaches across various sectors.
What's next for Enlitic?
With its recent major strategic investment, Enlitic is poised for accelerated growth and further development of its innovative software solutions. The substantial capital infusion is expected to fuel expansion into new markets, enhance research and development efforts, and strengthen its competitive position. This strategic financing will likely enable Enlitic to scale its operations, refine its product offerings, and solidify its commitment to advancing patient care through cutting-edge medical device software. The company's focus on regulatory compliance and quality assurance suggests a strategic approach to market penetration and long-term sustainability.
See full Enlitic company page
